A de novo p.Arg756Cys mutation in ATP1A3 causes a distinct phenotype with prolonged weakness and encephalopathy triggered by fever

• DOI: 10.1016/j.braindev.2017.09.010
• Publication Date: 2017-10-23T17:54:10Z
• Authors: Yuji Nakamura; Ayako Hattori; Mitsuko Nakashima; Daisuke Ieda; Ikumi Hori; Yutaka Negishi; Naoki Ando; Naomichi Matsumoto; Shinji Saitoh
• Keywords: Male; Brain Diseases; Fever; DNA Mutational Analysis; Arginine; 3. Good health; 03 medical and health sciences; Phenotype; 0302 clinical medicine; Child, Preschool; Mutation; Humans; Cysteine; Sodium-Potassium-Exchanging ATPase

Patients with a mutation at Arg756 in ATP1A3 have been known to exhibit a distinct phenotype, characterized by prolonged weakness and encephalopathy, triggered by febrile illness. With only eight reports published to date, more evidence is required to correlate clinical features with a mutation at Arg756. Here we report an additional case with an Arg756Cys mutation in ATP1A3. A four-year-old boy showed mild developmental delay with recurrent paroxysmal episodes of weakness and encephalopathy from nine months of age. Motor deficits, which included bilateral hypotonia, ataxia, dysmetria, limb incoordination, dysarthria, choreoathetosis, and dystonia, were observed from one year and three months. Whole-exome sequencing detected a heterozygous de novo variant at c.2266C>T (p.Arg756Cys) in ATP1A3. The episodic course and clinical features of this case were consistent with previously reported cases with mutations at Arg756. Furthermore, his phenotype of marked ataxia was more similar to that of an Arg756Cys patient with relapsing encephalopathy and cerebellar ataxia syndrome, than to those with Arg756His and Arg756Leu mutations. This report therefore provides evidence of genotype-phenotype correlations in ATP1A3-related disorders as well as in patients with mutations at Arg756 in ATP1A3.